ADMINISTRATION of large doses of cytokines by injection is required to induce changes in acute phase protein levels.
Introduction
Acute phase proteins (APPs) are defined as those proteins produced by the liver whose levels change during the course of inflammation or trauma. 4 This mediator was later purified, defined as a cytokine and named interleukin-1. Subsequently, a number of cytokines involved in inducing changes in liver synthesis have been identified, purified and cloned. The main cytokines recognised as inducing changes in liver synthesis of APPs are interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor (TNF).
All of these cytokines have been shown to induce APP changes in cultured hepatocytes, hepatoma (C) 1992 Rapid Communications of Oxford Ltd. cells 6'7 and also induce changes in the plasma levels of animals after injection. 8'9 The concentrations of the cytokines required to induce changes in APPs in vivo have been much greater than those used in vitro because of the short half-life of the cytokines in blood. 1'11 In inflammatory conditions, release of the cytokines is more likely to be continuous rather than spasmodic, therefore to model these effects in vivo a method of sustained release of the cytokines is required. The aim of this study was to investigate the effects of interleukin-lo on APP levels in the rat after single and multiple injection and to compare these effects with IL-I administered by slow release from implanted osmotic minipumps. Further studies were made using slow release of recombinant human IL-lfl, TNFo and IL-6 in the rat in order to determine the role of these cytokines in the induction of individual APPs.
Materials and Methods
Animals: In all the experiments described, female, Allen and Hanbury Hooded strain rats were used. The rats weighed between 90 and 160g and were aged between 8 and 12 weeks old. The animals were provided with tap water and Spillers PCD diet ad libitum throughout the experiment.
Collection ofplasma: Ether anaesthetized rats were bled from the dorsal tail artery using a heparin rinsed (Liquemine, Roche; 500 U/ml) 1 (Tables 1 and 2) induced different degrees of changes in haptoglobin The APP levels in plasma were determined 4 days after implantation of the pumps. Rats dosed with vehicle alone from the minipumps has significantly lower plasma levels of albumin (*p < 0.05) and greater levels of caeruloplasmin (*p < 0.05) than non-implanted rats (no minimpump). Significant changes in the levels of albumin (*p < 0.05) were obtained from rats administered with 0.6 ng h -1 Administration of IL-I at higher doeses of 2.1,6.3, and 21 n h induced dose dependent changes in all the APPs measured, most of the changes were statistically significantly different from the vehicle alone group (**p < 0.01 to ***p < 0.001 as determined by Student's t-test (unpaired, two-tailed and TNF (-'-I-'-) on plasma APP levels are shown after continuous release of the cytokines for 5 days. Statistical significance to the vehicle control group is shown as *p < 0.05; **p < 0.01 and ***p < 0.001 according to Student's t-test (unpaired; two-tailed). also produced a variable exudate inside the granuloma in three out of five rats. had similar effects to those seen with IL-lfl, but rhlL-lfl was ten times more active than rhlL-10 in this rat model (Fig. 1) . 
